Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1971 1
1995 1
2000 1
2001 5
2003 3
2004 4
2005 3
2007 2
2008 2
2009 2
2010 5
2011 2
2012 1
2013 2
2014 3
2015 2
2016 1
2017 1
2018 5
2019 7
2020 4
2021 7
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis.
Andreotti F, Geisler T, Collet JP, Gigante B, Gorog DA, Halvorsen S, Lip GYH, Morais J, Navarese EP, Patrono C, Rocca B, Rubboli A, Sibbing D, Storey RF, Verheugt FWA, Vilahur G. Andreotti F, et al. Eur Heart J. 2023 Jan 21;44(4):262-279. doi: 10.1093/eurheartj/ehac515. Eur Heart J. 2023. PMID: 36477865
Key consensus points include efforts to improve medical adherence through deprescribing and polypill use; adoption of universal risk definitions for bleeding, myocardial infarction, stroke and cause-specific death; multiple bleeding-avoidance strategies, ranging from gastroprotec …
Key consensus points include efforts to improve medical adherence through deprescribing and polypill use; adoption of universal risk definit …
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
REMAP-CAP Writing Committee for the REMAP-CAP Investigators; Bradbury CA, Lawler PR, Stanworth SJ, McVerry BJ, McQuilten Z, Higgins AM, Mouncey PR, Al-Beidh F, Rowan KM, Berry LR, Lorenzi E, Zarychanski R, Arabi YM, Annane D, Beane A, van Bentum-Puijk W, Bhimani Z, Bihari S, Bonten MJM, Brunkhorst FM, Buzgau A, Buxton M, Carrier M, Cheng AC, Cove M, Detry MA, Estcourt LJ, Fitzgerald M, Girard TD, Goligher EC, Goossens H, Haniffa R, Hills T, Huang DT, Horvat CM, Hunt BJ, Ichihara N, Lamontagne F, Leavis HL, Linstrum KM, Litton E, Marshall JC, McAuley DF, McGlothlin A, McGuinness SP, Middeldorp S, Montgomery SK, Morpeth SC, Murthy S, Neal MD, Nichol AD, Parke RL, Parker JC, Reyes LF, Saito H, Santos MS, Saunders CT, Serpa-Neto A, Seymour CW, Shankar-Hari M, Singh V, Tolppa T, Turgeon AF, Turner AM, van de Veerdonk FL, Green C, Lewis RJ, Angus DC, McArthur CJ, Berry S, Derde LPG, Webb SA, Gordon AC. REMAP-CAP Writing Committee for the REMAP-CAP Investigators, et al. JAMA. 2022 Apr 5;327(13):1247-1259. doi: 10.1001/jama.2022.2910. JAMA. 2022. PMID: 35315874 Free PMC article. Clinical Trial.
INTERVENTIONS: Patients were randomized to receive either open-label aspirin (n = 565), a P2Y12 inhibitor (n = 455), or no antiplatelet therapy (control; n = 529). ...Intervention equivalence was defined as greater than 90% probability that the OR (compared with each other …
INTERVENTIONS: Patients were randomized to receive either open-label aspirin (n = 565), a P2Y12 inhibitor (n = 455), or no antiplatel …
The dual role of citrate in cancer.
Icard P, Simula L, Zahn G, Alifano M, Mycielska ME. Icard P, et al. Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):188987. doi: 10.1016/j.bbcan.2023.188987. Epub 2023 Sep 17. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37717858 Review.
[Refractory proctitis].
Seksik P, Daniel F, Marteau P, Beaugerie L, Cosnes J. Seksik P, et al. Gastroenterol Clin Biol. 2007 Apr;31(4):393-7. doi: 10.1016/s0399-8320(07)89398-5. Gastroenterol Clin Biol. 2007. PMID: 17483776 Free article. Review. French. No abstract available.
[Aortic stenosis in the elderly: The TAVI revolution].
Overtchouk P, Collet JP. Overtchouk P, et al. Presse Med. 2019 Feb;48(2):165-172. doi: 10.1016/j.lpm.2018.11.007. Epub 2018 Dec 10. Presse Med. 2019. PMID: 30545690 Review. French.
Conduction disturbance, stroke, bioprosthesis thrombosis and durability are the main setbacks of TAVI. Double antiplatelet therapy with aspirin and clopidogrel during 3 to 6 months is currently recommended after TAVI, followed by long-term aspirin single therapy....
Conduction disturbance, stroke, bioprosthesis thrombosis and durability are the main setbacks of TAVI. Double antiplatelet therapy with a …
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.
Nadarajah R, Ludman P, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Gale CP; NSTEMI Investigators. Nadarajah R, et al. Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):8-15. doi: 10.1093/ehjqcco/qcac067. Eur Heart J Qual Care Clin Outcomes. 2022. PMID: 36259751
The registry collected data relating to baseline characteristics, major outcomes (in-hospital death, acute heart failure, cardiogenic shock, bleeding, stroke/transient ischaemic attack, and 30-day mortality) and guideline-recommended NSTEMI care interventions: electrocardiogram p …
The registry collected data relating to baseline characteristics, major outcomes (in-hospital death, acute heart failure, cardiogenic shock, …
Extracellular Citrate and Cancer Metabolism-Letter.
Icard P, Fournel L, Alifano M, Lincet H. Icard P, et al. Cancer Res. 2018 Sep 1;78(17):5176. doi: 10.1158/0008-5472.CAN-18-1666. Epub 2018 Aug 16. Cancer Res. 2018. PMID: 30115701 No abstract available.
Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases.
Jourdi G, Lordkipanidzé M, Philippe A, Bachelot-Loza C, Gaussem P. Jourdi G, et al. Int J Mol Sci. 2021 Dec 3;22(23):13079. doi: 10.3390/ijms222313079. Int J Mol Sci. 2021. PMID: 34884884 Free PMC article. Review.
Over the last decades, antiplatelet agents, mainly aspirin and P2Y(12) receptor antagonists, have significantly reduced morbidity and mortality associated with arterial thrombosis. ...
Over the last decades, antiplatelet agents, mainly aspirin and P2Y(12) receptor antagonists, have significantly reduced morbidity and …
[Premature ovarian failure: which protocols?].
Merviel P, Lourdel E, Boulard V, Cabry R, Claeys C, Oliéric MF, Sanguinet P, Brasseur F, Henri I, Copin H. Merviel P, et al. Gynecol Obstet Fertil. 2008 Sep;36(9):872-81. doi: 10.1016/j.gyobfe.2008.06.015. Epub 2008 Aug 13. Gynecol Obstet Fertil. 2008. PMID: 18703373 Review. French.
Will be thus analyzed the natural cycles (or semi-natural), the increase in the dose of gonadotrophins, the clomiphene citrate and the anti-aromatases, the protocols with GnRH agonists long, short, stop or microdoses, the protocols with GnRH antagonists and the adjuvant treatment …
Will be thus analyzed the natural cycles (or semi-natural), the increase in the dose of gonadotrophins, the clomiphene citrate and the anti- …
67 results